Abstract
New inhibitors of IL-4 signal transduction, designated as TMC-256A1 and C1, were discovered together with TMC-256B1, a previously known dihydronaphthopyrone, from the fermentation broth of Aspergillus niger var niger TC 1629 by using an IL-4 driven reporter gene assay. Based on spectroscopic analyses, TMC-256A1 and C1 were found to be new members of the naphthopyrone antibiotics. TMC-256A1, B1 and C1 inhibited the IL-4 driven luciferase activity with IC50 values of 25 microM, 30 microM and 1.7 microM, respectively in this assay system. Furthermore, these compounds inhibited the expression of germline C epsilon mRNA with IC50 values of 6.6 microM , 34 microM and 0.31 microM, respectively.
MeSH terms
-
Anti-Bacterial Agents / chemistry
-
Anti-Bacterial Agents / metabolism
-
Anti-Bacterial Agents / pharmacology*
-
Aspergillus niger / classification
-
Aspergillus niger / metabolism*
-
B-Lymphocytes / immunology
-
Chromones / chemistry
-
Chromones / metabolism*
-
Chromones / pharmacology
-
HeLa Cells
-
Humans
-
Immunoglobulin E / metabolism
-
Interferon-gamma / pharmacology
-
Interleukin-4 / antagonists & inhibitors*
-
Interleukin-4 / pharmacology
-
Luciferases / genetics
-
Luciferases / metabolism
-
Lymphocyte Activation
-
Magnetic Resonance Spectroscopy
-
Naphthalenes / chemistry
-
Naphthalenes / metabolism
-
Naphthalenes / pharmacology*
-
Pyrones / chemistry
-
Pyrones / metabolism
-
Pyrones / pharmacology*
-
RNA, Messenger / drug effects
-
RNA, Messenger / metabolism
-
Signal Transduction / drug effects*
-
Transfection
-
Tumor Cells, Cultured
Substances
-
Anti-Bacterial Agents
-
Chromones
-
Naphthalenes
-
Pyrones
-
RNA, Messenger
-
TMC 256A1
-
TMC 256C1
-
Interleukin-4
-
Immunoglobulin E
-
Interferon-gamma
-
Luciferases